Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.
type: Distribution
access URL: https://hal.univ-brest.fr/hal-00935796
format: HTML
issued: 2026-05-07T06:48:02.273938
modified: 2026-05-07T06:48:02.217539

test_moissonnage_selune
type: Agent

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.
type: Dataset
contact point: Organization
  fn: CCSD
keyword: journal-articles
keyword: mesh-recurrence
keyword: mesh-international-normalized-ratio
keyword: mesh-adult
keyword: mesh-follow-up-studies
keyword: sdvlife-sciences-q-bio
keyword: mesh-beta-alanine
keyword: mesh-venous-thromboembolism
keyword: mesh-warfarin
keyword: mesh-female
keyword: mesh-middle-aged
keyword: mesh-humans
keyword: mesh-male
keyword: infoeu-reposemanticsarticle
keyword: mesh-risk
keyword: mesh-young-adult
keyword: mesh-intention-to-treat-analysis
keyword: mesh-aged-80-and-over
keyword: mesh-aged
keyword: mesh-benzimidazoles
keyword: mesh-adolescent
keyword: mesh-hemorrhage
landing page: 0028-4793
description: International audience
issued: 2026-05-07T06:48:02.264934
language: en
modified: 2026-05-07T06:48:02.264940